Topic search: CARDIOLOGY

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Refine your search by entering keywords here:

Cardiology Journal Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2025 Pg. 279-290	Stability Study of Pediatric Oral Suspensions Formulated with PCCA SuspendIt Vehicle Used for the Treatment of Cardiovascular Disease Author(s): Davis Courtaney, Ip Kendice, Banov Daniel, Zdoryk Oleksandr
Jul/Aug 2025 Pg. 293	Clonidine Hydrochloride 0.1 mg/mL Oral Liquid Author(s):
Jul/Aug 2025 Pg. 310-318	Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary Evaluation Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
May/Jun 2024 Pg. 242	Amlodipine Besylate Veterinary Suspension Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 244	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 358-360	Major Study Affirming the Relative Safety of Testosterone-replacement Therapy Author(s): Biundo Bruce
Sep/Oct 2023 Pg. 362-366	Compounding Metformin for Use in Functional Medicine Author(s): Desai Sarina, Thompson Tara
Jul/Aug 2023 Pg. 326	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 340-346	Formulation and In Vitro Evaluation of a Ramipril Entrapped in a Microsponge-based Drug-delivery System Author(s): Taghi Hassanien Sagban, Abdulbaqi Mustafa R, Samein Laith Hamza, Rahmani Maha H Philip
Mar/Apr 2023 Pg. 153	Timolol 0.125%/Mucolox 15%/0.9% Normal Saline Nasal Spray Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 510	Diazoxide 10-mg/mL in Oral Mix SF Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 522-526	Intravenous Physical Compatibility of Heparin Sodium and Furosemide Author(s): Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
Sep/Oct 2022 Pg. 364-368	A Compendium of Compounding Agents and Formulations, Part 5: Timolol and Beta-glucans Author(s): Riepl Mike
Jul/Aug 2022 Pg. 321-322	Furosemide 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 323-324	Hydralazine Hydrochloride 10 mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 234	Candesartan Cilexitil 1 mg/mL Syrup Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 148	Propranolol 2 mg/mL and 5 mg/mL in Ora-Blend SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 155-162	Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Author(s): Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Jan/Feb 2022 Pg. 56	Enalapril Maleate 1 mg-mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 501	Kayexalate in Lactulose Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 503	Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 504	Propranolol 2 mg/mL or 5 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 413	Cilazapril 1-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 414	Clonidine 0.01-mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 421	Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 320	Apixaban 0.25-mg/mL Suspension for Enteral Feeding Tube Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 327	Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 329	Valsartan 4-mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 236-240	Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design Author(s): Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia
Mar/Apr 2021 Pg. 142	Amlodipine 1-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 163-168	Stability of Extemporaneously Compounded Nadolol 10-mg/mL Suspension in Oral Mix in Glass and Plastic Bottles and Plastic Syringes Author(s): Walsh Andrea, Ziegler Blake, Lingertat-Walsh Karen, Law Shirley, Walker Scott E
Jan/Feb 2021 Pg. 45	Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 46	Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 318	Lisinopril 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 246-251	Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days Author(s): Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara
Mar/Apr 2020 Pg. 130	Acetazolamide 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 136	Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 139	Valsartan 4 mg/mL in Syrup NF Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 54	Amiodarone Hydrochloride 5 mg/mL in SyrSpend SF pH4 Cherry Flavored Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 61	Potassium Chloride 1 mmol/mL in Ora-Sweet SF Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 64-68	Long-term Physicochemical Stability of Concentrated Solutions of Isosorbide Dinitrate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence M
Nov/Dec 2019 Pg. 494	Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 519-527	Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt Author(s): Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
Sep/Oct 2019 Pg. 408	Dipyridamole 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 412	Valsartan 4 mg/mL in Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 413	Verapamil Hydrochloride 50 mg/mL in Ora-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Sep/Oct 2019 Pg. 414-417	Stability of Furosemide 5 mg/mL in Polypropylene Syringes Author(s): van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
Sep/Oct 2019 Pg. 434-437	Long-term Physiochemical Stability of Concentrated Solutions of Salbutamol (Albuterol) in Polypropylene Syringes for Use in the Intensive Care Unit and in Obstetrics Author(s): Lardinois Benjamin, Baltzis Alexandre, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin Benoît, Hecq Jean-Daniel, Galanti Laurence
Jul/Aug 2019 Pg. 315	Candesartan Cilexetil 1 mg/mL in Syrup NF or Vehicle for Oral Solution USP Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 324-331	Extemporaneous Indomethacin Oral Suspension Prepared from Injectable Ampules for Therapy in Premature Infants and Pediatric Patients Author(s): de Lafuente Yanina, García Mónica Cristina, Jiminez-Kairuz Alvaro
May/Jun 2019 Pg. 232	Clopidogrel 5 mg/mL in a Sugar-Free Syrup Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 237	Valsartan 16-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 147	Amlodipine 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 148	Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 152	Rosuvastatin 20-mg/5-mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 163-166	Evaluation of the Physicochemical Stability of Amiodarone Hydrochloride in Syringes for the Intensive Care Unit Author(s): Lardinois Benjamin, Dimitriou Alexandre, Delcave Charlotte, Jamart Jacques, Bihin Benoît, Soumoy Laura, Hecq Jean-Daniel, Galanti Laurence M
Jan/Feb 2019 Pg. 55	Magnesium Sulfate and Lidocaine Hydrochloride Injection in Prefilled Syringes Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 57	Minoxidil 1-mg/mL in Ora-Plus and Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 70-76	Stability of Compounded Ursodiol Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Miller Valicia, Morris Tommy C, Graves Richard A
Nov/Dec 2018 Pg. 493	Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 494	Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 411	Torsemide 5 mg/mL in Ora-Plus:Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 322	Minoxidil 50 mg/mL in Espumil Foam Base Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 324	Pentoxifylline 5% in Dermabase Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 325	Propranolol Hydrochloride 1 mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 335-339	Long-term Physicochemical Stability of Concentrated Solutions of Noradrenaline Bitartrate in Polypropylene Syringes for Administration in the Intensive Care Unit Author(s): Lardinois Benjamin, Pector Johan, Delcave Charlotte, Soumoy Laura, Jamart Jacques, Bihin B, Hecq Jean-Daniel, Galanti Laurence M
May/Jun 2018 Pg. 233	Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 238	Simvastatin 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 152	Spironolactone 5-mg/mL in Suspendit Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 50	Glutamate and Aspartate Cardioplegia Additive Solution Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 496	Spironolactone 5 mg/mL in SuspendIt Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 315	Disopyramide 100-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 317	Reteplase Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 320	Torsemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 334-338	Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Author(s): Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
May/Jun 2017 Pg. 232	Candesartan Cilexetil 0.1-mg/mL to 2.0-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 147	Candesartan Cilexetil 8 mg Liquid-Filled Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 148	Furosemide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 150-153	Stability of Alprostadil in 0.9% Sodium Chloride Stored in Polyvinyl Chloride Containers Author(s): McCluskey Susan V, Kirkham Kylian, Munson Jessica M
Jan/Feb 2017 Pg. 61	Diazoxide 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 505	Bosentan 6.25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 512	Melatonin 2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 408	Inamrinone 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 435-437	Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Author(s): Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
Jul/Aug 2016 Pg. 277-280	Case Report: Pediatric Scar Management After Open-heart Surgery Author(s): Phan Ha, Harger Beau, Estrada Nick
Jul/Aug 2016 Pg. 328-332	Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Jul/Aug 2016 Pg. 343-346	Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump Author(s): Tomasello Cristina, Leggieri Anna, Rabbia Franco, Veglio Franco, Baietto Lorena, Fulcheri Chiara, De Nicolò Amedeo, De Perri Giovanni, D'Avolio Antonio
May/Jun 2016 Pg. 234	Sodium Nitroprusside 25-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 247-249	Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children Author(s): Nahata Milap C
Mar/Apr 2016 Pg. 145	Carvedilol 3.125-mg, 6.25-mg, 12.5 mg, or 25-mg capsules Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 513	Propranolol Hydrochloride Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 367-373	Compounding Pharmacies' Potential to Create Graft Storage Solutions for Bypass Surgeries Author(s): Guth Michael AS
Sep/Oct 2015 Pg. 407	Nimodipine 3-mg/mL Oral Solution Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 289-293	Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity Author(s): Biundo Bruce, Gogola Margaret
May/Jun 2015 Pg. 195-203	Compounded Testosterone Troches to optimize Health and the Testosterone Controversy Author(s): Guth Michael AS
Mar/Apr 2015 Pg. 143	Aminohippurate Sodium 200-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 145	Heparin 335-United/Gram Gel-Cream Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 147	Morrhuate Sodium 5% Injection Author(s): Allen Loyd V Jr
Mar/Apr 2015 Pg. 152-160	Transdermal Delivery of Nisoldipine: Refinement of Vehicles Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Jan/Feb 2015 Pg. 60	Atenolol 25-, 50-, or 100-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 65	Hydralazine Hydrochloride 20-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 69	Phentolamine Mesylate 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 411	Ephedrine Sulfate 50-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 413	Indocyanine green 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 326	Chlorothiazide 50-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 330	Propranolol Hydrochloride 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 203-207	Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Author(s): Phan Ha, DeReese Annie, Day A J, Carvalho Maria
May/Jun 2014 Pg. 232	Atorvastatin 10-mg or 20-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 233	Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 142	Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2014 Pg. 152-158	Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride Author(s): Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
Mar/Apr 2014 Pg. 169-174	Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets Author(s): Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu
Jan/Feb 2014 Pg. 61	Bumetanide 0.25-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 65	Nimodipine 30-mg Capsules Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 67	Potassium Chloride 2-mEq/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 68	Procainamide Hydrochloride 100-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 515-519	Stability of Nitroglyercin 100 mcg/mL Stored in Polypropylene Syringes Author(s): McCluskey Susan V, Vu Nicole, Rueter John
Sep/Oct 2013 Pg. 419	Indomethacin 1-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 422	Phenylephrine Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 436-438	Compatibility of Amiodarone Hydrochloride with Vasopressin During Simulated Y-site Administration Author(s): Ramaley Corrine C, Li Feng, Du Chengan
Jul/Aug 2013 Pg. 333	Metoprolol Tartrate 1-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 336-338	Stability of Captopril in SyrSPend SF Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
May/Jun 2013 Pg. 233	Labetalol 50-mg Capsules Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 237	Reserpine 0.5-mg Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 144	Adenosine 3-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 149	Dexrazoxane 1-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2013 Pg. 153	Verapamil Hydrochloride 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 24-27	Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil? Author(s): Wung Deanna
Jan/Feb 2013 Pg. 65	Dobutamine 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 69	Milrinone 0.2-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 71	Nicardipine Hydrochloride Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 504	Dipyridamole 5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2012 Pg. 513-515	Stability of Propranolol Hydrochloride in SyrSpend SF Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Sep/Oct 2012 Pg. 419	Enalaprilat 1.25-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2012 Pg. 420	Esmolol Hydrochloride 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 338	Methyldopate Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 342-346	Formulation and Stability Evaluation of Extemporaneously Prepared Atenolol Capsules from Crushed Atenolol Tablets Author(s): Zaid Abdel Naser, Malkieh Numan, Kharoaf Maher, Ghoush Abeer Abu, Al-Ramahi Rowa'
May/Jun 2012 Pg. 182-188	A Concise Discussion of Headache Types, Part 2: Migraine Author(s): Williams LaVonn A
May/Jun 2012 Pg. 241	Diltiazem Hydrochloride 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 154	Amiodarone Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 158	Furosemide 10-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 160	Labetalol Hydrochloride 5-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2012 Pg. 80-81	Chemical Stability of Pentoxifylline in a Topical Cream Author(s): Gupta Vishnu D
Jan/Feb 2012 Pg. 12-16	Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs Author(s): McElhiney Linda F
Jan/Feb 2012 Pg. 34-41	Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Author(s): Helms Scott R, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2012 Pg. 72	Magnesium Sulfate 10% Injection (0.8 mEq/mL) Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 358-366	Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Author(s): Zur Eyal
Sep/Oct 2011 Pg. 418	Carvedilol 0.625-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 421	Metoprolol Tartrate 1.25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 422	Nifedipine 1-mg/500-mg Oral Powder Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 423	Nifedipine 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 425	Sotalol 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2011 Pg. 290-300	Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Author(s): Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R
May/Jun 2011 Pg. 255-258	Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Author(s): Voudrie Mark A, Alexander Bridget, Allen D Brett
May/Jun 2011 Pg. 259-261	Compatibility of Parenteral Furosemide with Seventeen Secondary Drugs Used in Standard Concentrations Author(s): Jasti Bhaskara R, Saraf Poonam
Mar/Apr 2011 Pg. 158	Clopidogrel 5-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 166-169	Nifedpine in Compounded Oral and Topical Preparations Author(s): McCluskey Susan V, Brunn Gregory J
Jan/Feb 2011 Pg. 71	Sodium Nitroprusside and Sodium Thiosulfate Intravenous Admixture Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 488-491	Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Author(s): Rudner Shara, Browne Paul
Nov/Dec 2010 Pg. 465-471	The Clinical Use of Dehydroepiandrosterone in Postmenopausal Women Author(s): Bramwell Bethany L
Sep/Oct 2010 Pg. 423	Carvedilol 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 340	Fenoldopam Mesylate Injection Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 94-99	Emerging Evidence for Androgen Replacement Therapy in Aging Men Author(s): Bramwell Bethany L
Mar/Apr 2010 Pg. 108-111	Coenzyme Q10 Supplementation in the Treatment of Heart Disease Author(s): Bramwell Bethany L
Mar/Apr 2010 Pg. 157	Metolazone 10-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 26-31	Providing Consultation Services for Wellness Issues Related to Exercise, Weight Management, and Nutritional Support: Key Lifestyle Modification for Healthier Aging Author(s): Biundo Bruce
Jan/Feb 2010 Pg. 40-45	Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Author(s): Muller George, Young Thomas W, Reina Rachel, Caldwell Delmar R
Nov/Dec 2009 Pg. 494-496	Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male Author(s): Biundo Bruce
Sep/Oct 2009 Pg. 367-371	Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret Author(s): Williams LaVonn A, Riley Kari
Sep/Oct 2009 Pg. 429	Amlodipine Besylate 1 mg/mL Veterinary Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 335	Dexamethasone and Furosemide Injection Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 192-195	Elegant Compounded Solutions for the Treatment of Thrombosed External Hemorrhoids Author(s): Zur Eyal
Mar/Apr 2009 Pg. 161	Vasopressin Tannate 5 Pressor Units Per mL in Oil Injection Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 392-397	Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Author(s): Mixon William, Helms Scott R
Sep/Oct 2008 Pg. 448	Carnitine 400-mg/mL and Coenzyme Q10 10-mg/mL Solution Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 455	Propafenone 1.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 269	Valsartan 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 67	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2008 Pg. 70	Pentoxifylline 20-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 242	Benazepril 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 244	Folic Acid 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2007 Pg. 248	Losartan Potassium 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 122-124	Compounded Treatments for Erectile Dysfunction: A Common Complication of Diabetes Author(s): Fields Shannon W
Mar/Apr 2007 Pg. 154	Aspirin 80-mg/5-mL Oral Liquid, Anhydrous Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 160	Phenoxybenzamine Hydrochloride 2-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 71	Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 75	Methyldopa 25-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 76	Metolazone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 457	Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 405-408	Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 421-424	Taurine for the Treatment of Canine Dilated Cardiomyopathy Author(s): Vail Jane
Nov/Dec 2006 Pg. 452	Amiloride Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2006 Pg. 386	Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 302	Lisinopril 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 303	Nifedipine 4-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 304	Propranolol Hydrochloride 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2006 Pg. 306	Sildenafil Citrate 2.5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 220	Carvedilol 1.25-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 221	Enalapril Maleate 1-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 225	Mexiletine Hydrochloride 10-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 227	Quinapril 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 137	Amlodipine 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 140	Disopyramide Phosphate 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 144	Sotalol Hydrochloride 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 477	Isradipine 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 479	Quinidine Sulfate 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 399-401	Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion Author(s): Gupta Vishnu D
Sep/Oct 2005 Pg. 402-406	Stability of Sotalol Hydrochloride in Extemporaneously Prepared Oral Suspension Formulations Author(s): Sidhom Madiha B, Rivera Nadya, Almoazen Hassan, Taft David R, Kirschenbaum Harold L
May/Jun 2005 Pg. 201-205	Combating Cardiovascular Disease with Compounded Medications -- Part 2: Clinical and Compounding Issues for Antihypertensive Drugs Author(s): Harrington Catherine A, Cauffield Jacintha